Cancer Therapy
A section of Cancers (ISSN 2072-6694).
Section Information
In the last decades, cancer therapies have substantially improved cancer care and patients’ survival. The introduction of targeted therapies had a major impact on the management of cancer. However, millions of people still die from cancer every year and cancer drug resistance remains the Achilles' heel of cancer chemotherapeutics. Thanks to our increasing knowledge and understanding of the pathology, new cancer cells phenotypes and drug targets have emerged in the last years. The role of the tumor microenvironment in cancer promotion and progression as well as the plastic and dynamic nature of the disease have been unraveled and now pave the way to the development of new and innovative therapeutic strategies. In this section of Cancers, we aim at rapidly publishing contributions on all aspects of Cancer Therapy. We encourage the submission of manuscripts providing new and innovative therapeutic approaches as well as papers describing technologies and models developed for the discovery and the delivery of anticancer drugs. Systematic and perspective reviews are also welcome. Topics include, but are not limited to:
- Cancer therapeutics
- Targeted therapy
- Drug discovery
- Drug repurposing
- Structure-based design
- Target-based design
- Tumor drug delivery
- Tumor drug distribution
- Drug resistance
- Precision medicine
- Gain/loss of function screening
- Cancer cell plasticity
- Cancer cell metabolism
- Cell cycle checkpoint
- DNA repair
- Tumor-microenvironment interactions
- Extracellular vesicles
- Tumor heterogeneity
- Combination therapies
- Adaptive therapy
- Rechallenge therapy
- Radiotherapy
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Breast Cancer: Tailored Rehabilitation Strategies to Address the Challenge of Survivorship Issues (Deadline: 3 July 2025)
- Impact of Surgery on Brain Cancer and Other Central Nervous System Tumors (Deadline: 15 July 2025)
- New Approaches in Radiotherapy for Cancer (Deadline: 15 July 2025)
- Recent Updates on Treatment of Uveal Melanoma (Deadline: 15 July 2025)
- Advanced Research on Radioresistant Tumors (Deadline: 15 July 2025)
- The Elderly Multiple Myeloma Patient in the Era of Quad Therapy and CAR-T Cells (Deadline: 15 July 2025)
- Epigenetic Therapeutic Targets in Cancer (Deadline: 24 July 2025)
- Ibrutinib in Chronic Lymphocytic Leukemia (Deadline: 25 July 2025)
- Liver Cancer: Improving Standard Diagnosis and Therapy: 2nd Edition (Deadline: 25 July 2025)
- Advantages and Benefits: Proton Therapy vs. X-Ray Treatment in Cancer (Deadline: 25 July 2025)
- Hepatocellular Carcinoma: Current Treatment Strategies for Advanced Disease and Recurrence: 2nd Edition (Deadline: 25 July 2025)
- New Approaches to Biology and Treatment of Acute Leukemia (Deadline: 30 July 2025)
- The Genetic Analysis and Clinical Therapy in Lung Cancer (Deadline: 30 July 2025)
- Genetic Analysis and Clinical Therapy in Head and Neck Cancers (Deadline: 30 July 2025)
- Recent Developments in Proton Therapy of Head and Neck Cancer (Deadline: 30 July 2025)
- Updates in Chronic Lymphocytic Leukemia: 10 Years of Paradigm Change and Outlook for the Future (Deadline: 30 July 2025)
- Insights into Lymphoma Treatment (Deadline: 30 July 2025)
- Updates on Thyroid Cancer (Deadline: 30 July 2025)
- Emerging Paradigms for Cancer Therapy: Promises and Challenges (Deadline: 30 July 2025)
- Novel Targeted Therapies in Brain Tumors (Deadline: 31 July 2025)
- Gene and Cell Therapy for Cancers (Deadline: 31 July 2025)
- Prostate Cancer Therapy: Supporting Strategies and Management Options (Deadline: 31 July 2025)
- Genitourinary Malignancies (Deadline: 31 July 2025)
- Stereotactic Radiotherapy in Tumor Ablation: Second Edition (Deadline: 31 July 2025)
- Metronomic Chemotherapy in Cancer Treatment (Deadline: 31 July 2025)
- Multimodal Treatment for Pancreatic Cancer (Deadline: 31 July 2025)
- The Pathologic Diagnosis and Clinical Therapy of Neuroendocrine Tumors (Deadline: 31 July 2025)
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Cancer Therapy (Deadline: 31 July 2025)
- Emerging Research on Primary Brain Tumors (Deadline: 31 July 2025)
- Novel Diagnosis and Treatment Approaches in Pancreatic Cancer (Deadline: 31 July 2025)
- Thyroid Cancer: Diagnosis, Prognosis and Treatment (2nd Edition) (Deadline: 31 July 2025)
- Significance of CAR T-Cell Therapy in Aggressive B-Cell Lymphoma Treatment (Deadline: 31 July 2025)
- Glioma: From Intracellular Oncogenic Pathways to Targeting Therapeutic Strategies (Deadline: 31 July 2025)
- Pituitary Tumors: Molecular Insights, Diagnosis, and Targeted Therapy (2nd Edition) (Deadline: 1 August 2025)
- Novel Therapies in Metastatic Castration-Resistant Prostate Cancer (Deadline: 1 August 2025)
- BRCA Associated Cancers: Latest Predictive and Therapeutic Approaches (Deadline: 1 August 2025)
- Radiomics in Cancer (Deadline: 1 August 2025)
- miRNAs in Targeted Cancer Therapy (Deadline: 1 August 2025)
- Breast Cancer and Hormone-Related Therapy (Deadline: 10 August 2025)
- Research on Early-Stage Breast Cancer: Management and Treatment (Deadline: 15 August 2025)
- Advancements in Lung Cancer Surgical Treatment and Prognosis (Deadline: 15 August 2025)
- Advances in Skin Cancer: Diagnosis, Treatment and Prognosis (Deadline: 15 August 2025)
- Clinical Surgery for Hepato-Pancreato-Biliary (HPB) Cancer (Deadline: 15 August 2025)
- Breast Conservation and Radiotherapy in the Era of De-Escalation of Breast Cancer Treatments (Deadline: 15 August 2025)
- Advances in Esophageal Cancer (Deadline: 15 August 2025)
- Antioxidants in Cancers (Deadline: 15 August 2025)
- Palliative Radiotherapy of Cancer (Deadline: 15 August 2025)
- Radiotherapy for Sarcoma (Deadline: 15 August 2025)
- Robot-Assisted Surgery for Urologic Cancer (Deadline: 15 August 2025)
- Advances in Neoadjuvant Therapy for Urologic Cancer (Deadline: 17 August 2025)
- New Insights into Esophageal Cancer Chemotherapy (Deadline: 20 August 2025)
- Exploring Non-Coding RNA Signatures in Cancer: Definitions and Implications for Diagnosis and Therapy (Deadline: 20 August 2025)
- New Challenges in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (Deadline: 29 August 2025)
- Surgical Treatment of Bone Metastases: 2nd Edition (Deadline: 29 August 2025)
- Modern Approach to Oral Cancer (Deadline: 30 August 2025)
- Chemo-Radio-Immunotherapy for Colorectal Cancer (Deadline: 30 August 2025)
- New Therapies and Immunological Findings in Nasopharyngeal Carcinoma (Deadline: 31 August 2025)
- Recent Advances on the Role of Intensity–Modulated Radiotherapy in Cancer (Deadline: 31 August 2025)
- Pathogenesis and Treatment Strategies in Multiple Myeloma: From Basic Research to Real Life (Deadline: 31 August 2025)
- Advances in Proton Therapy for Head and Neck Cancer: Techniques, Outcomes and Planning Variations (Deadline: 31 August 2025)
- Modern Pathology, Artificial Intelligence and Personalized Therapy in Gastrointestinal Cancer (Deadline: 31 August 2025)
- New Insights into Robotic Surgery for Urologic Cancer (Deadline: 31 August 2025)
- Research on Fluorescence-Guided Surgery in Cancer Treatment (Deadline: 31 August 2025)
- Advancing Horizons in Colorectal Surgery: Innovative Approaches and Outcomes (Deadline: 31 August 2025)
- Advances in the Management of Prostate Cancer: New Insights into Biological and Clinical Factors (Deadline: 31 August 2025)
- Emerging Therapies in the Management of Gastrointestinal Malignancies (2nd Edition) (Deadline: 31 August 2025)
- Updates on Urologic Oncology: From Diagnosis to Localized and Systemic Therapy Options (2nd Edition) (Deadline: 31 August 2025)
- Current Treatments of Esophageal and Esophagogastric Junction Cancers (Deadline: 31 August 2025)
- Meningioma Recurrences: Risk Factors and Management (Deadline: 31 August 2025)
- Combination Therapy in Lymphoma (Deadline: 31 August 2025)
- Advances in the Management of Pelvic Tumors (Deadline: 1 September 2025)
- The Role of Aromatase Inhibitors in Breast Cancer Treatment (Deadline: 1 September 2025)
- New Perspectives in the Treatment of Thoracic Cancers (Deadline: 1 September 2025)
- Drug Utilization, Safety and Effectiveness of Anti-Cancer Drugs for Solid Tumors: A Focus on Special Populations (Deadline: 5 September 2025)
- Surgical Advances in the Treatment of Gliomas: Preserving Function and Quality of Life (Deadline: 7 September 2025)
- Advances in Interventional Oncologic Therapies (Deadline: 15 September 2025)
- Hematopoietic Stem Cell Transplant in Hematological Malignancies (Deadline: 15 September 2025)
- Radioligand Therapy (RLT) in Neuroendocrine Neoplasms (Deadline: 15 September 2025)
- Skin Cancers of the Head and Neck (Deadline: 15 September 2025)
- Neuroendocrine Neoplasms: Pathogenesis, Diagnostics, and Therapy (Deadline: 17 September 2025)
- Communication and Accessibility in the Tumor Microenvironment as a Therapeutic Target (Deadline: 20 September 2025)
- New Insights into Urologic Oncology (Deadline: 20 September 2025)
- Multimodality Imaging for More Precise Radiotherapy (Deadline: 20 September 2025)
- Rare Breast Tumors (Deadline: 25 September 2025)
- Adjuvant Therapy for Pancreatic Cancer (Deadline: 30 September 2025)
- The Application of Laparo-Endoscopic and Robotic Surgery in Cancer Treatments and Research (Deadline: 30 September 2025)
- Advances in Systemic Therapy and Radiotherapy for the Treatment of Lung Cancer (Deadline: 30 September 2025)
- Hematologic Malignancies and Related Disorders: Challenges from Diagnosis to Treatment (Deadline: 30 September 2025)
- Targeting RNA to Improve Cancer Precision Medicine (Deadline: 30 September 2025)
- Treatment Options and Risk Factors of Pancreatic Neuroendocrine Neoplasms (Deadline: 30 September 2025)
- Multiple Myeloma: Diagnosis and Therapy (Deadline: 30 September 2025)
- Neoadjuvant Chemoradiotherapy for Gastrointestinal Cancer (Deadline: 30 September 2025)
- Contemporary Management for Gallbladder Cancer: From Diagnosis to Treatment (2nd Edition) (Deadline: 30 September 2025)
- The Development and Application of Imaging Biomarkers in Cancer (Deadline: 30 September 2025)
- Radiation Therapy in Lung Cancer: From a Technical Revolution to a Combination with New Systemic Approaches (2nd Edition) (Deadline: 30 September 2025)
- Treatment of Hepatopancreatobiliary Cancers: Open Question, Challenge, and Future Directions (2nd Edition) (Deadline: 30 September 2025)
- Integrated Management of Cancer (2nd Edition) (Deadline: 30 September 2025)
- Soft Tissue Sarcomas—New Diagnostic and Therapeutic Perspectives Through Clinical Genomic Profiling (Deadline: 30 September 2025)
- Pheochromocytoma, Paraganglioma and Neuroblastoma: Focus on Genetics—the Never-Ending Story (Deadline: 30 September 2025)
- Innovative Strategies and Techniques in Diagnosing, Treating and Surveying Soft Tissue Sarcomas (Deadline: 30 September 2025)
- Developments, Challenges and Uncertainties in Delivering Stereotactic Ablative Body Radiotherapy to Solid Tumours (Deadline: 30 September 2025)
- Radiobiological Modelling in the New Era of Precision Radiation Oncology (Deadline: 1 October 2025)
- Skin Cancer: Epidemiology, Management and New Therapies (Deadline: 1 October 2025)
- Updates on Liver Cancer Management (Deadline: 1 October 2025)
- Recent Research on Soft Tissue Sarcomas (Deadline: 6 October 2025)
- Imaging in Breast Cancer Diagnosis and Treatment (Deadline: 15 October 2025)
- De-escalation of Axillary and Breast Cancer Surgery in the Setting of Neo-Adjuvant Chemotherapy (Deadline: 15 October 2025)
- First-Line Therapy in Thoracic Oncology (Deadline: 15 October 2025)
- Inflammatory Bowel Disease and Cancers (Deadline: 15 October 2025)
- Treatments of Uveal Melanoma (Deadline: 15 October 2025)
- Head and Neck Cancer Recurrence: Diagnosis, Treatment and Prognosis (2nd Edition) (Deadline: 15 October 2025)
- Liquid Biopsy in Cancer 2.0 (Deadline: 20 October 2025)
- Prostate Cancer: Contemporary Standards and Challenges (Deadline: 23 October 2025)
- Radiation Therapy for Brain Tumors (Deadline: 25 October 2025)
- Research on Surgical Treatment for Ovarian Cancer (Deadline: 25 October 2025)
- Study on Acute Myeloid Leukemia (Deadline: 25 October 2025)
- Treg Cell Immunotherapy in Cancer (Deadline: 30 October 2025)
- Advances in TNBC: New Markers for Innovative Treatments (Deadline: 31 October 2025)
- Management of Pancreatic Cancer (Deadline: 31 October 2025)
- Treatment Outcomes in Older Adults with Cancer (Deadline: 31 October 2025)
- Combination Therapies for Brain Tumors (Deadline: 31 October 2025)
- Neurosurgical Management of Gliomas (Deadline: 31 October 2025)
- Neo-Adjuvant Treatment of Breast Cancer (Deadline: 31 October 2025)
- Neurofibromatosis (Deadline: 31 October 2025)
- A New Era in the Treatment of Early-Stage Non-Small Cell Lung Cancer (Deadline: 31 October 2025)
- Targeted Therapies for EGFR in Non-Small Cell Lung Cancer (Deadline: 31 October 2025)
- Gastrointestinal Cancer Surgery (Deadline: 31 October 2025)
- Prognosis and Treatment of Cutaneous Melanoma (2nd Edition) (Deadline: 31 October 2025)
- Epigenetic Regulators and Cancer Precision Therapies (Deadline: 31 October 2025)
- Proton and Light Ion Therapy for Cancer (Deadline: 31 October 2025)
- Advances in Skin Cancer Diagnostics and Therapy: Research and Clinical Studies (2nd Edition) (Deadline: 31 October 2025)
- News and How Much to Improve in Management of Soft Tissue Sarcomas (Deadline: 31 October 2025)
- Advances in Targets for CAR T Therapy in Hematologic Malignancies (Deadline: 31 October 2025)
- New Strategies for the Treatment of Melanoma and Non-Melanoma Skin Cancer (Deadline: 31 October 2025)
- Advances in Thoracic Oncology Research (Deadline: 1 November 2025)
- Discoveries in Targeted Therapies for Melanoma: From Molecular Mechanisms to Therapeutics (Deadline: 1 November 2025)
- Targeted Therapy for Liver Metastases (Deadline: 1 November 2025)
- Advancing Hepatocellular Imaging: Innovations in Diagnosis, Prognosis, and Treatment Response Assessment (Deadline: 5 November 2025)
- Advances of Particle Therapy in Prostate Cancer—2nd Edition (Deadline: 5 November 2025)
- Hematological Malignancie: Progress and Challenges (Deadline: 7 November 2025)
- Upper Tract Urothelial Carcinoma: Current Knowledge and Perspectives (Deadline: 10 November 2025)
- Advances in Therapeutic Approaches Targeting Pediatric and Adult Glioma (Deadline: 15 November 2025)
- Radiotherapy for Thoracic Malignancies: New Advances and Challenges: 2nd Edition (Deadline: 15 November 2025)
- Benign and Malignant Neoplasms of the Head and Neck (Deadline: 15 November 2025)
- Advances in Radiomic, Genomic and Radiogenomic Techniques in Pediatric Medulloblastoma (Deadline: 15 November 2025)
- Minimally Invasive Gastric Cancer Surgery (Deadline: 15 November 2025)
- Cancer Treatment: Present and Future of Radioligand Therapy (Deadline: 20 November 2025)
- Advances in Soft Tissue and Bone Sarcoma (2nd Edition) (Deadline: 25 November 2025)
- Advances in Brachytherapy in the Treatment of Tumors (Deadline: 30 November 2025)
- Recent Advances in Skin Cancers (Deadline: 30 November 2025)
- Advancements in Surgical Approaches for Gynecological Cancers (Deadline: 30 November 2025)
- Advances in Esophagogastric Cancer (Deadline: 30 November 2025)
- Novel Therapeutic Approaches for Cancer Treatment (Deadline: 30 November 2025)
- New and Future Focused Therapies for Thyroid Cancer (Deadline: 30 November 2025)
- Cell Therapy in Solid Cancers: Current and Future Landscape (Deadline: 30 November 2025)
- Targeting Tumor Microenvironment in Cancer: An Impact on Therapeutic Efficacy (Deadline: 30 November 2025)
- Advances in Castration-Resistant Prostate Cancer Treatment (Deadline: 30 November 2025)
- New Approaches in the Treatment of Hepatocellular Carcinoma and Liver Tumor (Deadline: 30 November 2025)
- Mesothelioma: Diagnosis and Therapy (Deadline: 30 November 2025)
- New Approaches in Modulating Transcription Factors for Cancer Therapy 2nd Edition (Deadline: 30 November 2025)
- Evolution of B-Cell Malignancy Therapy and Treatment Resistance: Where Are We Headed? (2nd Edition) (Deadline: 30 November 2025)
- Surgery in Metastatic Cancer (2nd Edition) (Deadline: 30 November 2025)
- Radiotherapy for Head and Neck Squamous Cell Carcinoma (2nd Edition) (Deadline: 30 November 2025)
- Advances in Targeted Therapies in Cancer (2nd Edition) (Deadline: 30 November 2025)
- Non-Coding RNAs and Extracellular Vesicles in Cancer Crosstalk: Diagnostic and Therapeutic Implications 2nd Edition (Deadline: 30 November 2025)
- Clinical and Surgical Therapy for Colorectal Cancer (Deadline: 30 November 2025)
- Targeted Therapies in Pancreatic Cancer—Current Landscape and Future Directions (Deadline: 30 November 2025)
- Advances in the Surgical Treatment of Spinal Tumors (Deadline: 30 November 2025)
- Gastrointestinal and Its Associated Malignancies: Diagnosis, Targets and Therapies (Deadline: 1 December 2025)
- Mesothelioma—from Diagnosis to Treatment (Deadline: 5 December 2025)
- New Advances in Oncology Research and Practice (Deadline: 10 December 2025)
- The Impact of Treatment Resistance in Prostate Cancer (Deadline: 10 December 2025)
- Molecular Markers and Targeted Therapy for Hepatobiliary Tumors (Deadline: 15 December 2025)
- Clinical Treatment and Prognostic Factors of Urologic Cancer (Deadline: 15 December 2025)
- Advances in B-cell Lymphoma: From Diagnostics to Cure (Deadline: 15 December 2025)
- Signaling Pathways in Breast Cancer: 2nd Edition (Deadline: 15 December 2025)
- Surgical Management of Non-Small Cell Lung Cancer (Deadline: 15 December 2025)
- Thoracic Neuroendocrine Tumors and the Role of Emerging Therapies (Deadline: 20 December 2025)
- The Impact of Minimally Invasive Surgery on Gynecologic Cancers (Deadline: 20 December 2025)
- Translational Cancer Research in Multiple Myeloma, with a Focus on Immune Therapies and Novel Agents – “The Bench Behind the Bedside” (Deadline: 20 December 2025)
- Diagnosis and Therapeutic Management of Gastrointestinal Cancers: 2nd Edition (Deadline: 20 December 2025)
- Advances in Blood Cancers: How We Define Success (Deadline: 25 December 2025)
- Advances in Ovarian Cancer Research and Treatment: 2nd Edition (Deadline: 25 December 2025)
- Novel Surgical Treatment Approaches in Advanced Gastrointestinal Neoplasms (Deadline: 30 December 2025)
- Combination Therapy in Geriatric Population with Cancer (2nd Edition) (Deadline: 30 December 2025)
- Palliative Radiotherapy for Cancer (Deadline: 30 December 2025)
- Advances in Chronic Lymphocytic Leukaemia (CLL) Research (Deadline: 31 December 2025)
- Novel Therapeutic Strategies in Salivary Gland Tumor (Deadline: 31 December 2025)
- Advances in Surgical Treatment of Urinary Tumors (Deadline: 31 December 2025)
- New Insights into Kidney Disease Development and Therapy Strategies (Deadline: 31 December 2025)
- Advances in Radiation Therapy for Head and Neck Cancer (Deadline: 31 December 2025)
- Oral Potentially Malignant Disorders and Oral Cavity Cancer (Deadline: 31 December 2025)
- Chemotherapy and Immunotherapy of Lung Cancer (Deadline: 31 December 2025)
- The Advance of Biomarker-Driven Targeted Therapies in Cancer (Deadline: 31 December 2025)
- Updates in Neuroendocrine Neoplasms (Deadline: 31 December 2025)
- Radiosurgery for Brain Tumors (Deadline: 31 December 2025)
- Advances in Ovarian Cancer Treatment: Past, Present and Future (Deadline: 31 December 2025)
- Surgery for Colorectal Cancer (Deadline: 31 December 2025)
- New Insights on Management of Acute Lymphoblastic Leukemia in the Contemporary Era (Deadline: 31 December 2025)
- The Applications of Artificial Intelligence in Gastroenterology (Deadline: 31 December 2025)
- Surgical Aspects of Ovarian/Tubal/Peritoneal Cancer Management (Deadline: 31 December 2025)
- New Perspectives in the Management of Breast Cancer (Deadline: 31 December 2025)
- Advances in Cell and Gene Therapy in Tumors: From Bench to Bedside (Deadline: 31 December 2025)
- Stereotactic Body Radiotherapy in Gynecologic Malignancies—a Practical Framework of SBRT, Chemoradiotherapy and Immunotherapy (Deadline: 31 December 2025)
- Novel Treatments for Ocular and Periocular Cancers (Deadline: 31 December 2025)
- Accelerated Partial Breast Irradiation (Deadline: 31 December 2025)
- Celebrating the 2024 Nobel Prize in Chemistry: Advancements in Artificial Intelligence and Machine Learning for Cancer Therapeutics (Deadline: 31 December 2025)
- New Perspectives in the Management of Central Nervous System (CNS) Tumors (Deadline: 31 December 2025)
- Perspectives on the Efficacy and Biomarkers of Immunotherapy and Targeted Therapy for Patients with Colorectal Cancer (Deadline: 31 December 2025)
- Views and Perspectives of Robot-Assisted Liver Surgery (2nd Edition) (Deadline: 31 December 2025)
- Unravelling Cancer Mechanism and Developing Novel Therapeutics: An Urgent Need to Treat Cancer (2nd Edition) (Deadline: 31 December 2025)
- Radioimmunotherapy, Neoadjuvant Immunotherapy, and Adjuvant Immunotherapy for Cancer (Deadline: 31 December 2025)
- New Insights into Microbial-Based Cancer Therapy (Deadline: 31 December 2025)
- Challenges and New Developments in the Diagnosis and Treatment of Sarcoma (Deadline: 31 December 2025)
- Feature Review for Cancer Therapy: 2nd Edition (Deadline: 31 December 2025)
- Head and Neck Cancer Surgery and Rehabilitation: A Bridge Between Medicine and Dentistry for Reconstruction with Regeneration (Deadline: 31 December 2025)
- New Diagnostic and Therapeutic Perspectives of Gynecological Carcinomas (Deadline: 31 December 2025)
- Optimizing Surgical Procedures and Enhancing Outcomes in the Management of Gastrointestinal Cancer (Deadline: 31 December 2025)
- Contemporary Trends and Advances in Minimally Invasive and Endoscopic Management of Genitourinary Malignancies (Deadline: 31 December 2025)
- Surgical Innovations in Advanced Gastric Cancer (Deadline: 31 December 2025)
- Next-Generation Cancer Therapies (Deadline: 31 December 2025)
- Multidisciplinary Treatment with Surgery and Chemotherapy of Liver Metastases from Colorectal Cancer (Deadline: 31 December 2025)
- Stereotactic Body Radiation and Stereotactic Ablative Radiotherapy Therapy for Cancers 2nd edition (Deadline: 31 December 2025)
- The Extracellular Matrix and Tissue Engineering: Roles in the Tumor Microenvironment and Implications for Cancer Treatment (Deadline: 31 December 2025)
- Neoadjuvant Chemotherapy in Pancreatic Cancer (Deadline: 31 December 2025)
- Advanced Research in Surgical Treatment for Spinal Tumors (Deadline: 31 December 2025)
- Feature Papers in the Section “Cancer Therapy” in 2025 (Deadline: 31 December 2025)
- Advanced Ovarian Cancer (2nd Edition) (Deadline: 31 December 2025)
- Advances in Genitourinary Cancer: Biomarkers, Immunotherapy and Novel Therapeutics (Deadline: 31 December 2025)
- Plasma and Cancer Treatment (Deadline: 31 December 2025)
- Advances in Minimally Invasive Surgery for Colorectal Cancer (Deadline: 31 December 2025)
- New Insights in Parotid Tumors (Deadline: 31 December 2025)
- Advances in Pancreatic Ductal Adenocarcinoma Diagnosis and Treatment 2nd Edition (Deadline: 31 December 2025)
- Modern Neurosurgical Management of Gliomas (Deadline: 31 December 2025)
- Novel Therapeutic Targets for Metastatic Lung Cancer (Deadline: 31 December 2025)
- Neoadjuvant Therapy of Breast Cancer (Deadline: 15 January 2026)
- Updates on Urothelial Carcinoma (Deadline: 15 January 2026)
- Advancements in Salivary Gland Tumors Management: From Diagnostic Imaging to Treatment Strategies (Deadline: 22 January 2026)
- The Advance of Pencil Beam Scanning Proton Beam Therapy in Cancers (Deadline: 30 January 2026)
- Advances in the Treatment of Upper Gastrointestinal Cancer (Deadline: 30 January 2026)
- Surgical Advances in Cancer Treatments: Exploring Innovative Approaches and Emerging Perspectives by the Italian College of Associate Professors of Surgery (Deadline: 31 January 2026)
- Recent Advances and Challenges in Breast Cancer Surgery: 2nd Edition (Deadline: 31 January 2026)
- Head and Neck Cancer: Survivorship Challenges and Therapeutic Approaches (Deadline: 31 January 2026)
- Surgery for Lung Cancer: Robot-Assisted Versus Video-Assisted Thoracoscopic Surgery and Open Thoracotomy (Deadline: 31 January 2026)
- Transformative Drug Innovations Reshaping Myeloma Treatment (Deadline: 31 January 2026)
- Post-Neoadjuvant Strategies in Breast Cancer (2nd Edition) (Deadline: 31 January 2026)
- Recent Advances in Pancreatic Surgery for Pancreatic Ductal Adenocarcinoma (2nd Edition) (Deadline: 31 January 2026)
- Neoadjuvant Therapy for Urologic Cancer (Deadline: 31 January 2026)
- Novel Perspectives in Hepato-Biliary and Pancreatic Cancer (Deadline: 31 January 2026)
- Curative Therapies for Non-Small and Small Cell Lung Cancers (Deadline: 31 January 2026)
- Novel Approaches in the Management of Gynecological Cancers (Deadline: 31 January 2026)
- Therapy for HER2 Breast Cancer (Deadline: 1 February 2026)
- New Insights into Cancer Radiotherapy (Deadline: 10 February 2026)
- Recent Developments in the Field of Radiotherapy Treatment for Lung Cancer (Deadline: 10 February 2026)
- Metronomic Chemotherapy in Female Cancers (Deadline: 14 February 2026)
- Advances in Surgical Treatment of Gynecological Cancers (Deadline: 14 February 2026)
- New Strategies in Diagnosis and Treatments for Brain Tumors: 2nd Edition (Deadline: 15 February 2026)
- New and Emerging Strategies for Targeting Genomic Instability and Overcoming Drug Resistance in Lung Cancer (Deadline: 15 February 2026)
- Neoadjuvant Therapy in Hepatopancreatobiliary Malignancies: Current Trends and Future Directions (Deadline: 15 February 2026)
- Diagnosis, Treatment and Prevention of Gastrointestinal Cancer (2nd Edition) (Deadline: 18 February 2026)
- Multiple Myeloma: Recent Advances in Diagnosis, Analysis and Therapeutic Management: 2nd Edition (Deadline: 20 February 2026)
- Radiation Therapy for Modern Management of Bone Metastases (2nd Edition) (Deadline: 25 February 2026)
- Advances in the Treatment of Gastrointestinal (GI) Cancers (Deadline: 27 February 2026)
- Challenges and Opportunities for Novel Therapeutic Strategies in Pediatric Oncology (Deadline: 28 February 2026)
- Improving Surgical Care for Patients with Hepatobiliary and Pancreatic Cancers (Deadline: 28 February 2026)
- Navigating the Landscape of Female Cancers: Recent Discoveries and Treatment Trends (Deadline: 28 February 2026)
- Diagnosis, Staging, and Management for Gynecologic Oncology (Deadline: 28 February 2026)
- State of the Art and Novelties in Multidisciplinary Approach to Soft Tissue and Bone Sarcomas (Deadline: 28 February 2026)
- Advances in PET/CT Application in Urological Cancer (Deadline: 28 February 2026)
- Cell Therapy in Hematological Malignancies (Deadline: 28 February 2026)
- Predictive and Prognostic Biomarkers for Response to Neoadjuvant Chemotherapy for Breast Cancer (Deadline: 28 February 2026)
- Advances in the Diagnosis and Treatment of Genitourinary Cancers (2nd Edition) (Deadline: 28 February 2026)
- Image-Assisted High-Precision Radiation Oncology (Deadline: 28 February 2026)
- State-of-the-Art Research on Multiple Myeloma Progression: 2nd Edition (Deadline: 28 February 2026)
- Evolution of Cancer Therapies: Access of Developing Countries to Modern Oncology (Deadline: 28 February 2026)
- Chronic Lymphocytic Leukemia: From Genetics to Therapy (Deadline: 28 February 2026)
- Advances in Radiotherapy for Gynecological Cancers (Deadline: 28 February 2026)
- Castration-Resistant Prostate Cancer: Progress and Promise: 2nd Edition (Deadline: 1 March 2026)
- RAS Proteins and Their Regulators in Human Cancer (Deadline: 10 March 2026)
- Study on Clinical Treatment of Brain Tumors (Deadline: 13 March 2026)
- State of the Art: Cardiothoracic Tumors (Deadline: 15 March 2026)
- Endometrial Cancer Therapy: Foundations and Future Directions (Deadline: 15 March 2026)
- Treatment of Acute Kidney Injury in Cancer Patients: From Theory to Practice (Deadline: 15 March 2026)
- Advances in Lung Cancer Treatment Strategies (Deadline: 15 March 2026)
- Neuroendocrine Tumors: From Diagnosis to Therapy (2nd Edition) (Deadline: 20 March 2026)
- Radiation Therapy in Lung Tumors: Recent Trends and Current Issues (Deadline: 21 March 2026)
- Neoadjuvant Therapy for Pancreatic Cancer (Deadline: 30 March 2026)
- Recent Advances in Hepatobiliary Cancers: From Diagnosis to Treatment (2nd Edition) (Deadline: 31 March 2026)
- Cardio-Oncology: An Emerging Paradigm in Modern Medicine: 2nd Edition (Deadline: 31 March 2026)
- Advances on Imaging and Treatment of Head and Neck Cancer (Deadline: 31 March 2026)
- Advances in Renal Cell Carcinoma (Deadline: 31 March 2026)
- The EGFR-Tyrosine Kinase Inhibitors (EGFR-TKIs) and Immune Checkpoint Inhibitors (ICIs) for Non-Small Cell Lung Cancer (Deadline: 31 March 2026)
- Advances in Invasive Breast Cancer: Treatment and Prognosis (2nd Edition) (Deadline: 31 March 2026)
- Recent Advances in the Understanding of Myelodysplastic Syndrome and Acute Myeloid Leukemia (2nd Edition) (Deadline: 31 March 2026)
- Clinical and Surgical Outcomes in the Management of Extremity Soft Tissue Sarcomas (2nd Edition) (Deadline: 31 March 2026)
- Contemporary Lung Cancer Nodal Staging and Evolving Therapeutic Paradigms (Deadline: 31 March 2026)
- Modern Approaches in Gastrointestinal (GI) Oncology: From Bench to Bedside (Deadline: 31 March 2026)
- Diagnosis and Therapy in Urothelial Cancer (Deadline: 31 March 2026)
- Oncology: State-of-the-Art Research in Austria (Deadline: 15 April 2026)
- State-of-the-Art Surgical Treatment for Lung Cancers (Deadline: 15 April 2026)
- Advances in Radiation Therapy for Brain Metastases (Deadline: 15 April 2026)
- Unique Perspectives in Cancer Signaling (2nd Edition) (Deadline: 18 April 2026)
- Research on Current Progress in Penile Cancer (Deadline: 25 April 2026)
- Surgical Treatment of Hepato-Pancreato-Biliary Cancers (Deadline: 27 April 2026)
- Head and Neck Cancer: Advanced PET/CT and MRI Imaging with a Focus on Current and Emerging Molecular Theranostics (Deadline: 28 April 2026)
- Medical Treatment for Urological Cancers (Deadline: 30 April 2026)
- Treatment Response Biomarkers in Hepatocellular Carcinoma: From Basic Science to Clinical Validation (Deadline: 30 April 2026)
- The Changing Paradigms in the Management of Thyroid Cancer (Deadline: 30 April 2026)
- Targeted Therapy in Head and Neck Cancer (Deadline: 30 April 2026)
- From Molecular Insights to Cancer Treatments: Progress in Translational Science (Deadline: 30 April 2026)
- Precision Medicine in Hematological Malignancies: Current Insights and Future Directions (Deadline: 30 April 2026)
- Lung Cancer: Major Pulmonary Resections and Lymph Node Dissection in the Era of Evolving Therapies (Deadline: 30 April 2026)
- Cancer Stem Cells: From Molecular Mechanisms of Development to Potential of Targeted Therapy (Deadline: 30 April 2026)
- Advances in the Treatment of Urological Cancer (Deadline: 30 April 2026)
- Recent Advances in the Fertility-Sparing Treatment of Gynecological Cancers (Deadline: 30 April 2026)
- Cellular Plasticity: Tumorigenesis and Therapy (2nd Edition) (Deadline: 30 April 2026)
- Urologic Cancer: Endoscopic, Laparoscopic, and Robot-Assisted Surgery Management (2nd Edition) (Deadline: 1 May 2026)
- Research Advances and Therapeutic Strategies (RATS) in Cardio-Oncology (Deadline: 1 May 2026)
- Endoscopic Advances in Gastrointestinal Oncology (Deadline: 15 May 2026)
- Gene Editing and Delivery for Cancer Therapy (2nd Edition) (Deadline: 15 May 2026)
- The Surgical Management of Colorectal Cancer (Deadline: 20 May 2026)
- Current Advances in Management of Neuroendocrine Neoplasms (Deadline: 30 May 2026)
- Advance in Treatment of Uveal Melanoma (Deadline: 31 May 2026)
- Local Management of Breast Cancer: The Evolving Relationship Between Radiotherapy and Surgery (Deadline: 31 May 2026)
- Focus on Focal Therapy for Prostate Cancer (Deadline: 31 May 2026)
- Developments in the Management of Gastrointestinal Malignancies (2nd Edition) (Deadline: 31 May 2026)
- Targeted Therapy in Gastrointestinal Cancer (2nd Edition) (Deadline: 31 May 2026)
- Multimodality Management of Sarcomas (2nd Edition) (Deadline: 31 May 2026)
- Advances in Surgical and Multimodal Treatments of Hepatopancreatobiliary Cancers (Deadline: 31 May 2026)
- Advances in Neoadjuvant Chemotherapy and Radiotherapy for Breast Cancer: Surgical Impact and Clinical Outcomes (Deadline: 31 May 2026)
- Image-Guided Radiotherapy in Head and Neck Cancer (Deadline: 31 May 2026)
- Current Status and Prospects of Multimodal Treatment for Upper Gastrointestinal Cancer (Deadline: 31 May 2026)
- Head and Neck Cancer: MRI and PET/CT Diagnosis and Surgical Treatment (Deadline: 31 May 2026)
- Proton Therapy of Cancer Treatment (Deadline: 1 June 2026)
- Current Updates and Future Directions in Neuroendocrine Neoplasms (NENs): Understanding Biology, Diagnosis, Management and Research Efforts in NENs (2nd Edition) (Deadline: 15 June 2026)
- Current Progress in Radiotherapy and Particle Therapy of Cancer (Deadline: 16 June 2026)
- p53 Family in Cancer: How Close Are We to the Clinic? (2nd Edition) (Deadline: 20 June 2026)
- New Challenges for Gastric Cancer—Gut Microbiota, Post-eradication and Chemotherapy (Deadline: 30 June 2026)
- Advances in the Prevention and Treatment of Liver Cancer (Deadline: 30 June 2026)
- New Insights into Thyroid Cancer Surgery (Deadline: 30 June 2026)
- Gynecologic Oncology: Clinical and Translational Research (Deadline: 30 June 2026)
- Advances in Abdominal Surgical Oncology and Intraperitoneal Therapies (Deadline: 30 June 2026)
- Cancer Inhibitory Receptors: Targeting Tumor Microenvironment Therapeutically (Deadline: 30 June 2026)
- Role of BCL-2 Family Proteins in Cancer: Therapeutic Advancements and Challenges (Deadline: 30 June 2026)
- Understanding the Molecular Basis and Immunobiology of Renal Cell Carcinoma and Exploring Novel Therapeutic Strategies (Deadline: 30 June 2026)
- Innovative Treatments Based on Genomic Aberrations in Leukemia and Lymphoma (Deadline: 30 June 2026)
- Hepatocellular Carcinoma: Clinical Evidence and Emerging Therapeutic Benefits (Deadline: 30 June 2026)
- PARP Inhibitors in Cancer Therapy (Deadline: 30 June 2026)
- Radiation Therapy in Oncology (Deadline: 30 June 2026)
- Research and Treatment of Hepatocellular Carcinoma (Deadline: 30 June 2026)
- Emerging Therapies for Germ Cell Tumors (Deadline: 30 June 2026)
- Circadian Rhythms, Cancers and Chronotherapy (2nd Edition) (Deadline: 30 June 2026)
- Pediatric Brain Tumors: Symptoms, Diagnosis and Treatments (Deadline: 1 July 2026)
- The Role of Radiotherapy, Immunotherapy and New Surgical Techniques in the Treatment of Lung Neoplasms (Deadline: 1 July 2026)
- Advances in Therapeutic Strategies for Prostate Cancer (Deadline: 1 July 2026)
- Current Status and Clinical Developments in Lung Cancer: What to Expect from Emerging Drugs? (2nd Edition) (Deadline: 20 July 2026)
- Rare Cancers, Diagnostic Challenges and Personalized Therapeutic Approaches in the 21st Century (2nd Edition) (Deadline: 20 August 2026)
- Cancer-Therapy-Related Adverse Events (2nd Edition) (Deadline: 1 September 2026)
- Novel Advancements in Prostate Cancer Surgery: Indications and Techniques (Deadline: 30 September 2026)
- New Findings in Targeting Cancer Proteins (Second Edition) (Deadline: 30 November 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Advances in Diagnostics and Treatment of Head and Neck Cancer
- Advances in Geriatric Oncology: Exploring Practical Ways to Optimize Treatment in Older Patients with Cancer (Closed)
- Advances in Multiple Myeloma Research and Treatment
- Advances in the Management of Hepatocellular Carcinoma
- Breast Cancer: From Pathophysiology to Prevention and Treatment (Closed)
- Breast Cancer—Therapeutic Challenges, Research Strategies and Novel Diagnostics (Closed)
- Cancer Nanomedicine
- Combination Therapies in Cancers
- Emerging Therapeutics in Advanced Melanoma
- Hyperthermia in Cancer Therapy
- Innovative Concepts in the Diagnosis and Treatment of Gynecologic Malignancies (Closed)
- Ion Channels in Cancer Therapies
- Neuroendocrine Tumors: Treatment and Management
- New Treatment for Colorectal Cancer
- Novel Therapies for Hepatocellular Carcinoma (Closed)
- Oncology: State-of-the-Art Research in the USA
- Particle Therapy: State-of-the-Art and Future Prospects
- Prostate Cancer: Pathophysiology, Pathology and Therapy (Closed)
- Targeted Cancer Therapy (Closed)
- Targeted Therapies and Immunotherapies in Metastatic Melanoma (Closed)
- Treatment of Glioma
- Treatment of Hepatocellular Carcinoma and Cholangiocarcinoma
- Urological Cancer 2023-2025 (Closed)
